Inherited BRCA2 mutation associated with high grade breast cancer

Breast Cancer Research and Treatment

Volumn 47, Issue 2, 1998, Pages 121-127

  Agnarsson, Bjarni A ^a   Jonasson, Jon G ^a   Björnsdottir, Ingveldur B ^b   Barkardottir, Rosa B ^a   Egilsson, Valgardur ^a   Sigurdsson, Helgi ^b  

^a UNIVERSITY OF ICELAND   (Iceland)

^b LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

Author keywords

BRCA2; Flow cytometry; Hereditary breast cancer; Malignancy grade; Tumor biology

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; CELL CYCLE S PHASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; GENE MUTATION; GERM LINE; HISTOLOGY; HUMAN; INHERITANCE; LUNG CARCINOMA; MEDULLARY CARCINOMA; MICROTUBULE; MITOSIS RATE; ONCOGENE; PRIORITY JOURNAL;

ADULT; AGED; BRCA2 PROTEIN; BREAST; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; FEMALE; GENETIC MARKERS; HUMANS; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; TRANSCRIPTION FACTORS;

EID: 0031983839     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1005853022804     Document Type: Article

References (27)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal PA, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett LM, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, McClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris FH, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A, Skolnick MH: A strong candidate for breast and ovarian cancer susceptibility gene BRCA1. Science 266: 66-71, 1994
2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficenec D, Kelsell D, Ford D, Tonin P, Bishop DT, Spurr NK, Ponder BAJ, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkardottir RB, Easton RB, Bentley DR, Futreal PA, Ashworth A, Stratton MR: Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792, 1995
3. Tavtigian SV, Simard J, Rommens J, Couch F, Shattuck-Eidens D, Neuhausen S, Meraiver S, Thorlacius S, Offit K, Stoppa-Lyonnet D, Belanger C, Bell R, Berry S, Bogden R, Chen Q, Davis T, Dumont M, Frye C, Hattier T, Jammulapati S, Janecki T, Jiang P, Kehrer R, Leblanc J-F, Mitchell JT, McArthur-Morrison J, Nguyen K, Peng Y, Samson C, Schroeder M, Snyder SC, Steele L, Stringfellow M, Stroup C, Swedlund B, Swensen J, Teng D, Thomas A, Tran T, Tranchant M, Weaver-Feldhaus J, Wong AKC, Shizuya H, Eyfjord JE, Cannon-Albright L, Fabrie F, Skolnick MH, Weber B, Kamb A, Goldgar DE: The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nature Genet 12: 333-337, 1996
4. Easton DF, Bishop DT, Ford D, Crockford GP: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. Am J Hum Genet 52: 678-701, 1993
5. Wooster R, Neuhausen S, Mangion J, Quirk Y, Ford D, Collins N, Nguyen K, Seal S, Tran T, Averill D, Fields P, Marshall G, Narod SA, Lenoir G, Lynch HT, Feunten J, Deville P, Cornelisse C, Menko F, Daly P, Ormiston W, McManus R, Pye C, Lewis C, Cannon-Albright L, Peto J, Ponder BAJ, Skolnick M, Easton D, Goldgar D, Stratton M: Localization of a breast cancer susceptibility gene. BRCA2, to chromosome 13q12-13. Science 265: 2088-2090, 1994
6. Easton DF, Ford D, Bishop DT, and the Breast Cancer Linkage Consortium: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Am J Hum Genet 56: 265-271, 1995
7. Narod S, Ford D, Devilee P, Barkardottir RB, Eyfjord J, Lenoir G, Serova O, Easton D, Goldgar D, and the Breast Cancer Linkage Consortium: Genetic heterogeneity of breast-ovarian cancer revisited. Am J Hum Genet 57: 957-958, 1995
8. Marcus JN, Watson P, Page DL, Lynch HT: Pathology and heredity of breast cancer in young women. Mongr Natl Cancer Inst 16: 23-34, 1994
9. Bignon Y-J, Fonck Y, Chassagne M-C: Histoprognostic grade in tumours from families with hereditary predisposition to breast cancer. Lancet 346: 258, 1995
10. Eisinger F, Stoppa-Lyonnet D, Longy M, Kerangueven F, Noguchi T, Bailly C, Vincent-Salomon A, Jacquemier J, Birnbaum D, Sobol H: Germ line mutation at BRCA1 affects the histoprognostic grade in hereditary breast cancer. Cancer Res 56: 471-474, 1996
11. Marcus MN, Watson P, Page DL, Nurod SA, Lenoir GM, Tonin P, Linder-Stephenson L, Salerno G, Conway TA, Lynch HT: Hereditary breast cancer. Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage. Cancer 77: 697-709, 1996
12. Gudmundsson J, Johannesdottir G, Arason A, Bergthorsson JT, Ingvarsson S, Egilsson V, Barkardottir RB: Frequent occurrence of BRCA2 linkage in Icelandic breast cancer families and segregation of a common BRCA2 haplotype. Am J Hum Genet 58: 749-756, 1996
13. Jonasson JG, Hrafnkelsson J: Nuclear DNA analysis and prognosis in carcinoma of the thyroid gland. A nationwide study in Iceland on carcinomas diagnosed 1955-1990. Virchows Archiv 425: 349-355, 1994
14. Jonasson JG, Agnarsson BA, Sigurdsson H: Prognostic value of tumour stage, histological grading and S-phase fraction in infiltrating ductal breast carcinomas. Int J Surg Pathol 2 (Suppl): 46, 1995
15. Tirkkonen M, Johansson O, Agnarsson B, Olsson H, Ingvarsson S, Karhu R, Tanner M, Isola J, Barkardottir RB, Borg A, Kallionemi O-P: Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germline mutations. Cancer Res 57: 1222-1227, 1997
16. Fisher B, Redmond C, Fisher E, Caplan R: Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06. J Clin Oncol 6: 1076-1087, 1988
17. Houlihan MJ, Goldwyn RM: Which patients should have a prophylactic mastectomy. Endocrine-Related Cancer 41: 15-21, 1992
18. Ricketts D, Turnbull L, Ryall G, Bakhshi R, Rawson NS, Gazet JC, Nolan C, Coombes RC: Estrogen and progesterone receptors in the normal female breast. Cancer Res 51: 1817-1822, 1991
19. Sigurdsson H, Agnarsson BA, Jonasson JG, Björnsdottir IB, Barkardottir RB, Gudlaugsdottir S, Egilsson V: Worse survival among breast cancer families carrying the BRCA2 susceptibility gene (Abstract). Breast Cancer Res Treat 37 (Suppl): 33, 1996
20. Langlands AO, Kerr GR, Bloomer SM: Familial breast cancer. Clin Oncol 2: 41-45, 1976
21. Lynch HT, Albano WA, Recabaren JA, Fain PR, Lynch PM: Survival in hereditary breast and colon cancer. JAMA 246: 1197, 1981
22. Albano WA, Recabaren JA, Lynch HT, Campbell AS, Mailliard JA, Organ CH et al.: Natural history of hereditary cancer of the breast and colon. Cancer 50: 360-363, 1982
23. Ruder AM, Moodie PF, Nelson NA, Choi NW: Does family history of breast cancer improve survival among patients with breast cancer? Am J Obstet Gynecol 158: 963-968, 1988
24. Anderson D, Badzioch MD: Survival in familial breast cancer patients. Cancer 58: 360-365, 1986
25. Lees AW, Jenkins HJ, May CL, Cherian G, Lam EWH, Hanson J: Risk factors and 10-year breast cancer survival in northern Alberta. Breast Cancer Res Treat 13: 143-151, 1989
26. Slattery ML, Berry TD, Kerber RA: Is survival among women diagnosed with breast cancer influenced by family history of breast cancer? Epidemiology 4: 543-548, 1993
27. Johannesdottir G, Gudmundsson J, Bergthorsson JT, Arason A, Agnarsson BA, Eiriksdottir G, Johansson OT, Borg A, Ingvarsson S, Easton DF, Egilsson V, Barkardottir RB: High prevalence of the 999del5 mutation in Icelandic breast and ovarian cancer patients. Cancer Res 56: 3663-3665, 1996